When?
Thursday, June 15, 2023, 5 pm

What?
Developing Molecular Therapeutics for Rare Diseases

Who?
Jude Samulski, co-founder of Asklepios BioPharmaceutical, Inc (AskBio) 

Where?
Colégio da Trindade

Host?
Luís Pereira de Almeida

Dr. Samulski received his Ph.D. in medical microbiology and immunology from the University of Florida. His graduate work (1978-82) demonstrated the first use of AAV2 as a viral vector which culminated in the first U.S. FDA approved gene therapy drug for Leber Congenital Amaurosis (LCA).

More information here.